Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inoperable Stage I/II Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Not applicableUnknownNCT01024829
What this trial is testing

Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC

Who this might be right for
NSCLC
The Netherlands Cancer Institute 150
Testing effectiveness (Phase 2)Study completedNCT00888823
What this trial is testing

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
AHS Cancer Control Alberta 13
Not applicableStudy completedNCT00346320
What this trial is testing

Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 80
Testing effectiveness (Phase 2)Study completedNCT00181506
What this trial is testing

HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy

Who this might be right for
Non-Small-Cell Lung Carcinoma
Maastricht Radiation Oncology 180
Testing effectiveness (Phase 2)Study completedNCT00023673
What this trial is testing

Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 63
Testing effectiveness (Phase 2)Study completedNCT00087438
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 59
Testing effectiveness (Phase 2)WithdrawnNCT00268255
What this trial is testing

Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Active Not RecruitingNCT04505267
What this trial is testing

NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+11 more
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Ended earlyNCT03148327
What this trial is testing

Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jonsson Comprehensive Cancer Center 18
Early research (Phase 1)UnknownNCT00006212
What this trial is testing

Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Center for Molecular Medicine
Not applicableActive Not RecruitingNCT05887011
What this trial is testing

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

Who this might be right for
Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III)
AstraZeneca 2,000
Testing effectiveness (Phase 2)Study completedNCT00002577
What this trial is testing

Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 36